These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8019834)

  • 1. AMPA receptor antagonists and local cerebral glucose utilization in the rat.
    Browne SE; McCulloch J
    Brain Res; 1994 Mar; 641(1):10-20. PubMed ID: 8019834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the non-NMDA receptor antagonist, 2,3-dihydro-6-nitro-7-sulfamoylbenzo(f)quinoxaline, on local cerebral glucose uptake in the limbic forebrain.
    Suzdak PD; Sheardown MJ
    J Neurochem; 1993 Oct; 61(4):1577-80. PubMed ID: 8397300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPA receptor antagonism attenuates MK-801-induced hypermetabolism in the posterior cingulate cortex.
    Patel TR; McCulloch J
    Brain Res; 1995 Jul; 686(2):254-8. PubMed ID: 7583291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
    Maj J; Rogóz Z; Skuza G; Jaros T
    Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of effects of the kappa-opioid agonist CI-977 on cerebral glucose utilization in rat brain.
    Mackay KB; McCulloch J
    Brain Res; 1994 Apr; 642(1-2):160-8. PubMed ID: 8032876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR; Teng YD; Marriott R
    Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional variations in the pharmacology of AMPA receptors as revealed by receptor autoradiography.
    Porter RH; Greenamyre JT
    Brain Res; 1994 Nov; 664(1-2):202-6. PubMed ID: 7534602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P; Diemer NH; Bruhn T; Johansen FF
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
    Bleakman R; Schoepp DD; Ballyk B; Bufton H; Sharpe EF; Thomas K; Ornstein PL; Kamboj RK
    Mol Pharmacol; 1996 Apr; 49(4):581-5. PubMed ID: 8609884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.
    Namba T; Morimoto K; Sato K; Yamada N; Kuroda S
    Brain Res; 1994 Feb; 638(1-2):36-44. PubMed ID: 8199874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo.
    Sato K; Morimoto K; Yamada N; Kuroda S; Hayabara T
    Brain Res; 1995 Jun; 683(2):279-82. PubMed ID: 7552367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia.
    Gill R; Lodge D
    Neuropharmacology; 1994 Dec; 33(12):1529-36. PubMed ID: 7760975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
    Kurumaji A; Nehls DG; Park CK; McCulloch J
    Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD; Jacobsen P; Honoré T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A crucial role of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures.
    Tortorella A; Halonen T; Sahibzada N; Gale K
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1401-5. PubMed ID: 9067329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal brain after experimental intracerebral hemorrhage in rat.
    Ardizzone TD; Lu A; Wagner KR; Tang Y; Ran R; Sharp FR
    Stroke; 2004 Nov; 35(11):2587-91. PubMed ID: 15375303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the competitive AMPA receptor antagonist NBQX with hexobarbital.
    Dall V; Orntoft U; Schmidt A; Nordholm L
    Pharmacol Biochem Behav; 1993 Sep; 46(1):73-6. PubMed ID: 8255925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
    Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
    J Med Chem; 1996 May; 39(11):2219-31. PubMed ID: 8667365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.